Karel Oomsstraat 37

2018 Antwerpen



Foundation date





Gimv Life Sciences supports promising companies in the life sciences sector with venture capital. Gimv's long-term approach is particularly valuable in this capital-intensive sector characterised by long and unpredictable periods between initial investment and exit. To maximize return on investment and create short- and long-term value for the companies we invest in, Gimv Life Sciences is committed to active involvement at the Board of Directors level.

Upcoming events

Latest news

  • Mithra appoints experienced life sciences executive Christian Homsy* as Chairman

    17 hours ago

  • Oxurion reaches enrollment target in KALAHARI Phase 2, Part B trial of novel PKal inhibitor THR-149 in diabetic macular edema

    Friday May 26th 2023

  • How garbage disposal clogs in cells can lead to Alzheimer’s

    Friday May 26th 2023